Geneos Wealth Management’s Abercrombie & Fitch ANF Stock Holding History

Geneos Wealth Management’s Portfolio ANF Stock Details ANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4	Closed	-$503	–	2470
2025 Q4	$503	Buy	+4	New	+$350	﹤0.01%	2459
2025 Q3	–	Sell	-255	Closed	-$21.1K	–	2505
2025 Q2	$21.1K	Buy	+255	New	+$19.3K	﹤0.01%	2003
2025 Q1	–	Sell	-4	Closed	-$598	–	3075
2024 Q4	$598	Hold	4	–	–	﹤0.01%	2860
2024 Q3	$560	Hold	4	–	–	﹤0.01%	2543
2024 Q2	$711	Hold	4	–	–	﹤0.01%	2019
2024 Q1	$501	Buy	+4	New	+$456	﹤0.01%	2121
2023 Q1	–	Sell	-3,000	Closed	-$68.7K	–	2044
2022 Q4	$68.7K	Hold	3,000	–	–	﹤0.01%	943
2022 Q3	$46K	Hold	3,000	–	–	﹤0.01%	1053
2022 Q2	$51K	Hold	3,000	–	–	﹤0.01%	1268
2022 Q1	$95K	Buy	+3,000	New	+$104K	﹤0.01%	1113
2017 Q1	–	Sell	-28,084	Closed	-$337K	–	2060
2016 Q4	$337K	Buy	28,084 +27,918	+16,818%	+$415K	0.04%	337
2016 Q3	$2K	Sell	166 -63	-28%	-$1.22K	﹤0.01%	1743
2016 Q2	$4K	Hold	229	–	–	﹤0.01%	1547
2016 Q1	$7K	Buy	+229	New	+$6.43K	﹤0.01%	1405

Other funds holding ANF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBFIT Investments Singapore $842M AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Geneos Wealth Management's ANF Position: Q1 2026 in Review

Geneos Wealth Management sold out of Abercrombie & Fitch (ANF) in Q1 2026, closing a stake of 4 shares — an estimated $503 sold.

Geneos Wealth Management first reported a position in ANF in Q1 2016 and held it in 14 quarters. The position peaked at $337K in Q4 2016. 408 funds tracked by Wall St. Rank hold ANF as of Q1 2026.

Geneos Wealth Management reported no remaining Abercrombie & Fitch position as of Q1 2026 after selling out during the quarter.
Geneos Wealth Management sold 4 Abercrombie & Fitch shares in Q1 2026, an estimated $503.
Geneos Wealth Management first reported a position in Abercrombie & Fitch in Q1 2016 and held it in 14 quarters.
Geneos Wealth Management's Abercrombie & Fitch position peaked at $337K in Q4 2016.
408 funds tracked by Wall St. Rank held Abercrombie & Fitch as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.